New Hill Management invests in unlisted growth companies commercializing technological innovations and scientific advances, primarily in
New Hill Management invests in unlisted growth companies commercializing technological innovations and scientific advances, primarily in the UK. They are active in the growing private equity secondary market, purchasing portfolios of positions as well as making direct secondary investments that target a specific company. They also make primary investments in extremely promising companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 26, 2012
TeraView
|
Series Unknown | $5.50M | Manufacturing | Yes |
Apr 6, 2009
Karus Therapeutics
|
Series Unknown | £1M | Biotechnology | — |